Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 241 AL 255

An update on the interactions between Alzheimer's disease, autophagy and inflammation

Bostancıklıoğlu M.

Gene. 2019 Jul 15;705:157-166. doi: 10.1016/j.gene.2019.04.040. Epub 2019 Apr 25.

The Future of Caregiver Efficacy Research: Commentary on "Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers"

Schulz R.

Am J Geriatr Psychiatry. 2019 Sep;27(9):995-997. doi: 10.1016/j.jagp.2019.04.001. Epub 2019 Apr 10.

Transcranial Direct Current Stimulation Improves Cognitive Function in Mild to Moderate Alzheimer Disease: A Meta-Analysis

Cai M, Guo Z, Xing G, Peng H, Zhou L, Chen H, McClure MA, He L, Xiong L, He B, Du F, Mu Q.

Alzheimer Dis Assoc Disord. 2019 Apr-Jun;33(2):170-178. doi: 10.1097/WAD.0000000000000304.

Financial Risk Aversion and Incipient Dementia

Chapman BP, Phillips C.

Am J Geriatr Psychiatry. 2019 Aug;27(8):862-864. doi: 10.1016/j.jagp.2019.03.019. Epub 2019 Apr 2.

A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer's disease

Fatahian R, Bagheri SR, Sadeghi M.

Folia Neuropathol. 2019;57(1):1-5. doi: 10.5114/fn.2019.83825.

The Y(682)ENPTY(687) motif of APP: Progress and insights toward a targeted therapy for Alzheimer's disease patients

Matrone C, Iannuzzi F, Annunziato L.

Ageing Res Rev. 2019 Jul;52:120-128. doi: 10.1016/j.arr.2019.04.003. Epub 2019 Apr 27.

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer's disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial

Hong YJ, Han HJ, Youn YC, Park KW, Yang DW, Kim S, Kim HJ, Kim JE, Lee JH; ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg).

Alzheimers Res Ther. 2019 May 1;11(1):37. doi: 10.1186/s13195-019-0492-1.

The role of DKK1 in Alzheimer's disease: A potential intervention point of brain damage prevention?

Ren C, Gu X, Li H, Lei S, Wang Z, Wang J, Yin P, Zhang C, Wang F, Liu C.

Pharmacol Res. 2019 Jun;144:331-335. doi: 10.1016/j.phrs.2019.04.033. Epub 2019 Apr 28.

Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives

Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M.

Int J Mol Sci. 2019 Apr 30;20(9):2139. doi: 10.3390/ijms20092139.

Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective

Suidan GL, Ramaswamy G.

Int J Mol Sci. 2019 May 1;20(9):2161. doi: 10.3390/ijms20092161.

Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer's disease

Connelly PJ, Adams F, Tayar ZI, Khan F.

BMC Neurol. 2019 May 3;19(1):88. doi: 10.1186/s12883-019-1316-4.

[Roles of Mammalian Target of Rapamycin Signaling and Autophagy Pathway in Alzheimer's Disease]

Chang YF, Hu WM.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Apr 28;41(2):248-255. doi: 10.3881/j.issn.1000-503X.10802.

14-3-3/Tau Interaction and Tau Amyloidogenesis

Chen Y, Chen X, Yao Z, Shi Y, Xiong J, Zhou J, Su Z, Huang Y.

J Mol Neurosci. 2019 Aug;68(4):620-630. doi: 10.1007/s12031-019-01325-9. Epub 2019 May 6.

The Full Spectrum of Alzheimer's Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes

de la Monte SM.

Adv Exp Med Biol. 2019;1128:45-83. doi: 10.1007/978-981-13-3540-2_4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias